Spots Global Cancer Trial Database for Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate Cancer
Official Title: Radiation Therapy With or Without Curcumin Supplement in Treating Patients With Prostate Cancer
Study ID: NCT01917890
Study Description
Brief Summary: Prostate cancer is the second most incident cancer among male population worldwide. Radiation therapy by itself or along with surgery and chemotherapy are the main treatments for prostate cancer however prostate cancer cells are only modestly responsive or even unresponsive to the cytotoxic effects of radiotherapy. Recently some in vitro and in vivo studies showed radiosensitizing and radioprotective effects for curcumin. No clinical trial has been done in this area and it is not yet known whether radiation therapy is more effective with or without curcumin supplements in treating patients with prostate cancer.
Detailed Description:
Eligibility
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Oncology and radiotherapy department, Besat Hospital, Tehran, , Iran, Islamic Republic of
Contact Details
Name: Reza Rastmanesh, PhD
Affiliation: Clinical Nutrition & Dietetics Dept., Shahid Beheshti University of Medical Sciences,
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
